Skip to main content
Equibles

Spruce Street Capital LP

Position in ALEC — Alector, Inc.

CIK 2050194 NEW YORK, NY
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,223,146
-$294,150 QoQ
Shares Held
2,101,068
0.0% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#14
of 140 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Spruce Street Capital LP holds $397,390,268 across 24 Biotechnology names. ALEC ranks #22 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RLAY
Relay Therapeutics, Inc.
 2,984,125 $55,832,978
2 LBRX
Lb Pharmaceuticals Inc
 1,376,159 $44,663,240
3 RLMD
Relmada Therapeutics, Inc.
 6,391,328 $44,227,989
4 ANRO
Alto Neuroscience, Inc.
 1,353,047 $35,706,910
5 DNTH
Dianthus Therapeutics, Inc. /DE/
 354,816 $34,587,463
6 SVRA
Savara Inc
 3,452,576 $21,267,868
7 PCVX
Vaxcyte, Inc.
 306,047 $17,790,512
8 ELVN
Enliven Therapeutics, Inc.
 329,006 $16,697,054

All Filings in ALEC

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,223,146 2,101,068
2026-03-31 $4,517,296 2,101,068
2025-12-31 $1,744,058 1,117,986